NASONEX NASAL SPRAY

Država: Izrael

Jezik: angleščina

Source: Ministry of Health

Aktivna sestavina:

MOMETASONE FUROATE 50 MCG/DOSE

Dostopno od:

MERCK SHARP & DOHME ISRAEL LTD

Koda artikla:

D07AC13

Farmacevtska oblika:

SOLUTION

Pot uporabe:

NASAL

Izdeluje:

SCHERING-PLOUGH LAB.NV BELGIUM

Terapevtska skupina:

MOMETASONE

Terapevtske indikacije:

In adults and children 3 years of age and older to treat the symptoms of seasonal or perennial rhinitis. In patients 12 years old and above who have a history of moderate to severe symptoms of seasonal allergic rhinitis prophylactic treatment with Nasonex Aqueous Nasal Spary is recommended 2- 4 weeks prior to the anticipated start of the pollen season.

Datum dovoljenje:

2013-03-01